A Phase 1b Dose Escalation Trial of PSK®/Placebo With Docetaxel to Treat Metastatic Castration-resistant Prostate Cancer

This study is currently recruiting participants.

Verified May 2013 by Bastyr University

Sponsor:

Collaborators:

University of Washington

Fred Hutchinson Cancer Research Center

Information provided by (Responsible Party):

Bastyr University

ClinicalTrials.gov Identifier:

NCT01685489

First received: September 6, 2012

Last updated: May 13, 2013

Last verified: May 2013

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	August 2014
Estimated Primary Completion Date:	August 2014 (Final data collection date for primary outcome measure)